We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
-$91.8M
(-1.7%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-4.58%
Top 10 Holdings %
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$38.2M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$37.7M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$35.3M |
| 4 |
Icon
ICLR
|
+$30.9M |
| 5 |
CELG
Celgene Corp
CELG
|
+$29.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$63.8M |
| 2 |
Danaher
DHR
|
+$50.4M |
| 3 |
AutoZone
AZO
|
+$36.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$33.9M |
| 5 |
Biogen
BIIB
|
+$33.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.03% |
| 2 | Healthcare | 24.38% |
| 3 | Financials | 20.66% |
| 4 | Communication Services | 10.61% |
| 5 | Consumer Discretionary | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
SLR Investment Corp
SLRC
$706M
| $5.67M | 0.11% |
315,000
| – | – |
|
177
Ziff Davis
ZD
$1.9B
| $5.02M | 0.1% |
84,915
+13,677
| +19% | +$809K |
|
|
FRC
178
DELISTED
First Republic Bank
FRC
| $5.01M | 0.1% |
79,510
| – | – |
|
|
TMUSP
179
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $4.69M | 0.09% |
68,500
+30,000
| +78% | +$1.94M |
|
|
ALTR
180
DELISTED
Altera Corp
ALTR
| $4.61M | 0.09% |
+90,014
| New | +$4.2M |
|
181
Corning
GLW
$126B
| $4.21M | 0.08% |
+213,508
| New | +$4.57M |
|
|
OAK
182
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $4.12M | 0.08% |
77,500
| – | – |
|
|
TSNU
183
DELISTED
Tyson Foods, Inc.
TSNU
| $4.09M | 0.08% |
78,600
+15,000
| +24% | +$759K |
|
184
Gilead Sciences
GILD
$161B
| $4.08M | 0.08% |
34,850
+14,468
| +71% | +$1.58M |
|
185
American Express
AXP
$223B
| $3.97M | 0.08% |
51,031
+46,548
| +1,038% | +$3.69M |
|
|
POLY
186
DELISTED
Plantronics, Inc.
POLY
| $3.6M | 0.07% |
64,018
+12,018
| +23% | +$670K |
|
187
Cardinal Health
CAH
$53.4B
| $3.51M | 0.07% |
42,000
+2,000
| +5% | +$177K |
|
188
Amgen
AMGN
$203B
| $3.44M | 0.07% |
22,430
-4,562
| -17% | -$731K |
|
|
SOHU
189
Sohu.com
SOHU
$336M
| $3.32M | 0.06% |
+56,188
| New | +$3.64M |
|
190
Brookdale Senior Living
BKD
$3.62B
| $3.15M | 0.06% |
90,667
+1,500
| +2% | +$55.3K |
|
|
SWIR
191
DELISTED
Sierra Wireless
SWIR
| $3.11M | 0.06% |
+125,000
| New | +$4.04M |
|
192
Regeneron Pharmaceuticals
REGN
$68.8B
| $3.06M | 0.06% |
5,993
+71
| +1% | +$34.6K |
|
|
193
Biogen
BIIB
$29.9B
| $3M | 0.06% |
7,431
-83,352
| -92% | -$33.5M |
|
194
Comscore
SCOR
| $2.9M | 0.06% |
+2,727
| New | +$2.94M |
|
195
UnitedHealth
UNH
$382B
| $2.78M | 0.05% |
22,750
+750
| +3% | +$88.7K |
|
|
CCIH
196
DELISTED
Chinacache International Holdings Ltd
CCIH
| $2.77M | 0.05% |
+221,193
| New | +$2.99M |
|
197
Becton Dickinson
BDX
$43.1B
| $2.71M | 0.05% |
19,578
+615
| +3% | +$84.9K |
|
198
Varonis Systems
VRNS
$5.25B
| $2.66M | 0.05% |
360,657
+102,240
| +40% | +$806K |
|
|
PPBI
199
DELISTED
Pacific Premier Bancorp
PPBI
| $2.54M | 0.05% |
149,970
+118,820
| +381% | +$1.91M |
|
200
Pacira BioSciences
PCRX
$1.02B
| $2.47M | 0.05% |
34,920
+27,767
| +388% | +$2.19M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.
- Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
- Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
- Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
- Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
- Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
- Polar Capital opened 43 new positions and closed 61 in Q2 2015.
- Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.
Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.